Carvedilol Tablet, Film Coated
Product Images NDC 50090-2079

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-2079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

A survival analysis line graph titled 'Survival Analysis for COPERNICUS (Intent-to-Treat)' comparing mortality percentages over 21 months between two groups: Placebo and Carvedilol. The y-axis represents % Mortality, and the x-axis shows time in months. The graph indicates lower mortality in the Carvedilol group compared to Placebo.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

Figure showing a forest plot titled 'Effects on Mortality for Subgroups in COPERNICUS,' depicting hazard ratios with confidence intervals for various patient subgroups including gender, age, race, diabetes status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, with a reference line at hazard ratio 1.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

A survival analysis Kaplan-Meier curve labeled 'Survival Analysis for CAPRICORN (Intent-to-Treat)', showing mortality percentage over 24 months. The graph compares two groups: Placebo and Carvedilol, with mortality percentage on the vertical axis and time in months on the horizontal axis. Statistical significance (P=0.03) is noted.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing two forest plots of hazard ratios for various subgroups based on clinical factors such as age, sex, timing of randomization post-MI, prior IV/oral beta-blocker use, Killip class, thrombolytic therapy, PTCA, heart failure status, diuretics use during MI, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each hazard ratio is represented with a point estimate and confidence intervals along an axis from 0.4 to 1.3.*

FDA Label Image

Chemical Structure (Carvedilol Str)

Chemical structure diagram of Carvedilol, showing its molecular framework with rings, hydroxyl groups, and side chains typical of this active pharmaceutical ingredient.*

FDA Label Image

Label Image (Lbl500901064)

Carvedilol 6.25 mg film-coated tablet bottle label by A-S Medication Solutions. The label includes dosage strength, storage instructions (store at 68 to 77 degrees F, protect from moisture), lot number, and quantity of 60 tablets. It also displays UPC and NDC codes.*

FDA Label Image

Label Image (Lbl500901069)

The packaging label for Carvedilol 25 mg tablets from A-S Medication Solutions. The label indicates the product number 5977-0 and specifies that each film-coated tablet contains 25 mg of carvedilol. Storage instructions recommend keeping the product between 68 to 77 degrees Fahrenheit and protecting it from moisture. The container holds 60 tablets.*

FDA Label Image

Label Image (Lbl500902079)

Carvedilol 12.5 mg tablet label from A-S Medication Solutions. The label shows product and lot numbers, storage instructions to keep tablets at 68 to 77 degrees Fahrenheit and protect from moisture, and indicates a package size of 60 tablets. It includes the manufacturer's information and NDC details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.